Patents by Inventor Neal R. Cutler

Neal R. Cutler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of monochloroflosequinan in the treatment of sexual dysfunction
    Patent number: 7041677
    Abstract: The present invention described the administration of halogenated flosequinan derivatives and the enantiomers of halogenated flosequinan derivatives for the treatment of sexual dysfunction (in males and females) and for the treatment of cardiovascular disease.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: May 9, 2006
    Assignee: R.T. Alamo Ventures I, LLC
    Inventor: Neal R. Cutler
  • Methods for the treatment of central nervous system disorders in certain patient groups
    Patent number: 6995173
    Abstract: Methods and compositions for treating specific patient groups for Central Nervous System disorders, including but not limited to Tourette Syndrome, are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions comprising quinolinones (and derivatives thereof) in patients with symptoms of a Central Nervous System Disorder who are otherwise free of cardiac disease and/or who have not been given organic nitrates.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: February 7, 2006
    Assignee: R.T. Alamo Ventures I, LLC
    Inventors: Neal R. Cutler, John Sramek
  • Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
    Publication number: 20040191178
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine as a sublingual spray or aerosol, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: February 3, 2004
    Publication date: September 30, 2004
    Applicant: R.T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
    Patent number: 6685951
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine as a sublingual spray or aerosol, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: February 3, 2004
    Assignee: R. T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
    Publication number: 20030198669
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine alone (or a combination of DHE and caffeine) major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: November 25, 2002
    Publication date: October 23, 2003
    Applicant: R.T. Alamo Ventures I, LLC
    Inventors: Neal R. Cutler, Anthony DiSanto
  • Use of halogenated heterocyclic compounds in the treatment of sexual dysfunction and cardiovascular disease
    Publication number: 20030191152
    Abstract: The present invention described the administration of halogenated flosequinan derivatives and the enantiomers of halogenated flosequinan derivatives for the treatment of sexual dysfunction (in males and females) and for the treatment of cardiovascular disease.
    Type: Application
    Filed: October 28, 2002
    Publication date: October 9, 2003
    Applicant: R.T. Alamo Ventures I, LLC
    Inventor: Neal R. Cutler
  • Methods for the treatment of central nervous system disorders in certain patient groups
    Publication number: 20030130311
    Abstract: Methods and compositions for treating specific patient groups for Central Nervous System disorders, including but not limited to Tourette Syndrome, are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions comprising quinolinones (and derivatives thereof) in patients with symptoms of a Central Nervous System Disorder who are otherwise free of cardiac disease and/or who have not been given organic nitrates.
    Type: Application
    Filed: September 30, 2002
    Publication date: July 10, 2003
    Applicant: R.T. Alamo Ventures I, LLC
    Inventors: Neal R. Cutler, John Sramek
  • Treatment of sexual dysfunction in certain patient groups
    Publication number: 20030105128
    Abstract: Methods for treating specific patient groups for sexual dysfunction are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions in patients who are free of cardiac disease and/or who have not been given organic nitrates.
    Type: Application
    Filed: July 30, 2002
    Publication date: June 5, 2003
    Applicant: R.T. Alamo Ventures I, LLC
    Inventor: Neal R. Cutler
  • Treatment of cardiovascular disease with quinolinone enantiomers
    Patent number: 6562838
    Abstract: The present invention is directed to methods for treating cardiovascular disease comprising administering the enantiomers of flosequinan in subjects not concurrently treated with nitrites or nitrates.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: May 13, 2003
    Assignee: R. T. Alamo Ventures I, L.L.C.
    Inventors: Neal R. Cutler, John Sramek
  • Sustained release topiramate
    Publication number: 20030072802
    Abstract: The present invention is an improvement in the treatment of mania and depression by administering topiramate in a sustained-release formulation. The sustained-release formulation of the present invention may also be co-administered with anti-psychotics and anti-depressants.
    Type: Application
    Filed: October 11, 2001
    Publication date: April 17, 2003
    Applicant: R.T. Alamo Ventures, Inc.
    Inventor: Neal R. Cutler
  • PDE III inhibitors for treating sexual dysfunction
    Patent number: 6541487
    Abstract: Compositions that are selective PDE III inhibitors and that are effective to treat sexual dysfunction in males and females, including, but not limited to, erectile dysfunction in males. The compositions comprise halogenated quinolines, isoquinolines, quinolones, thioquinolones and 2-oxoquinolones, including derivatives thereof. The compounds can be taken orally or by a number of different routes or can be used to coat the interior of a condom to induce erection.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: April 1, 2003
    Assignee: R.T. Alamo Ventures I, LLC
    Inventor: Neal R. Cutler
  • Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine
    Publication number: 20030022910
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine across the oral mucosa, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: April 26, 2002
    Publication date: January 30, 2003
    Applicant: R.T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
    Publication number: 20030017994
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine as a sublingual spray or aerosol, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: April 26, 2002
    Publication date: January 23, 2003
    Applicant: R.T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Sublingual administration of dihydroergotamine for the treatment of migraine
    Publication number: 20030017175
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine sublingually, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: March 6, 2002
    Publication date: January 23, 2003
    Applicant: R.T. Alamo Ventures I, Inc.
    Inventor: Neal R. Cutler
  • Sublingual administration of dihydroergotamine for the treatment of migraine
    Publication number: 20030008005
    Abstract: The present invention is an improvement in the treatment of migraine headaches. By administering dihydroergotamine sublingually, major limitations of past treatments are circumvented thereby allowing for higher efficacy and fewer side effects of treatment at lower doses.
    Type: Application
    Filed: July 5, 2001
    Publication date: January 9, 2003
    Applicant: R.T. Alamo Ventures, Inc.
    Inventor: Neal R. Cutler
  • The treatment of sexual dysfunction with enantiomers
    Publication number: 20020147217
    Abstract: Methods for treating specific patient groups for sexual dysfunction are provided. The methods of the present invention comprise the utilization of enantiomers of flosequinan, and pharmaceutical compositions comprising flosequinan enantiomers, in patients who are free of cardiac disease, who have not been treated with a drug that causes hypotensive effects, and/or who have not been given organic nitrites or nitrates. Flosequinan enantiomers, and pharmaceutical compositions comprising flosequinan enantiomers are administered to patients intranasally, orally, topically, and/or through respiratory inhalation.
    Type: Application
    Filed: January 26, 2001
    Publication date: October 10, 2002
    Applicant: R.T. Alamo Ventures I, L.L.C.
    Inventors: Neal R. Cutler, John Sramek
  • METHODS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS IN CERTAIN PATIENT GROUPS
    Publication number: 20020147215
    Abstract: Methods and compositions for treating specific patient groups for Central Nervous System disorders, including but not limited to Tourette Syndrome, are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions comprising quinolinones (and derivatives thereof) in patients with symptoms of a Central Nervous System Disorder who are otherwise free of cardiac disease and/or who have not been given organic nitrates.
    Type: Application
    Filed: January 26, 2001
    Publication date: October 10, 2002
    Applicant: R.T. Alamo Ventures I, L.L.C.
    Inventors: Neal R. Cutler, John Sramek
  • Treatment of cardiovascular disease with quinolinone enantiomers
    Publication number: 20020143031
    Abstract: The present invention is directed to compositions and methods for treating cardiovascular disease. In a preferred embodiment, the present invention contemplates using the enantiomers of flosequinan (and formulations comprising flosequinan) in subjects not concurrently treated with nitrites or nitrates.
    Type: Application
    Filed: January 26, 2001
    Publication date: October 3, 2002
    Applicant: R.T. Alamo Ventures I, L.L.C.
    Inventors: Neal R. Cutler, John Sramek
  • TREATMENT OF GASTROPARESIS IN CERTAIN PATIENT GROUPS
    Publication number: 20020143030
    Abstract: Methods for treating specific patient groups for gastroparesis are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions comprising quinolinones (and derivatives) in patients with symptoms of gastroparesis who are otherwise free of cardiac disease and/or who have not been given organic nitrates.
    Type: Application
    Filed: January 26, 2001
    Publication date: October 3, 2002
    Applicant: R.T. Alamo Ventures I, L.L.C,
    Inventors: Neal R. Cutler, John Sramek
  • Methods for the treatment of central nervous system disorders in certain patient groups
    Patent number: 6458804
    Abstract: Methods and compositions for treating specific patient groups for Central Nervous System disorders, including but not limited to Tourette Syndrome, are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions comprising quinolinones (and derivatives thereof) in patients with symptoms of a Central Nervous System Disorder who are otherwise free of cardiac disease and/or who have not been given organic nitrates.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: October 1, 2002
    Assignee: R.T. Alamo Venturesi, LLC
    Inventors: Neal R. Cutler, John Sramek